Healthcare -
Biotechnology - NASDAQ - US
$ 0.3911
-0.19 %
$ 48.7 M
Market Cap
-0.62
P/E
MRSN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss MRSN - Mersana Therapeutics, Inc.
10 K
LAST VALUE
43.73%
2 YEAR CAGR
-16.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR